Transcatheter MitraClip implantation can be a successful alternative treatment for severe mitral regurgitation secondary to acute myocardial infarction in patients with high operative risk.
MitraClip may offer a feasible option in high-risk post-MI papillary rupture; leaves open need for prospective trials versus surgery.
Papillary muscle rupture after acute myocardial infarction (AMI) is a dreadful complication and it is associated with five percent of deaths following AMI. Surgery is the recommended treatment of choice; however, it is usually deferred due to the high risk of mortality. MitraClip implantation using a transcatheter approach is an alternative option for patients with severe mitral regurgitation (MR) following AMI or those with high operative risk. We report a case of a 68-year-old male patient who developed severe MR secondary to AMI and underwent successful mitral valve repair using the MitraClip device.
No takes yet. Share an insight, caveat, or question.
Yasin et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: